A growing trend for shedding unwanted pounds, this weight-loss technique may help many achieve their goals.
A number of payment rule changes and unknown future federal and state regulations loom ahead.
Value-based healthcare prioritizes positive outcomes and positions patients at the center of future healthcare systems.
The threat of antimicrobial resistance has increased substantially since the start of the COVID-19 pandemic, and while a host of diagnostic tools are available, these life-threatening infections still pose a threat due to limitations of tests, especially those that are rapid.
Due to the urgency in encouraging the public to get vaccinated against the SARS-CoV-2 virus, the message concerning the importance of widespread testing has been neglected, creating a lack of data needed for study by scientists.
While acetylcholinesterase inhibitors, corticosteroids and thymectomy are generally considered first-line therapies for MG, many patients additionally require proven immunosuppressive therapies (ISTs) such as azathioprine, cyclosporine/tacrolimus or mycophenolate mofetil, or immunomodulatory therapies, including intravenous immune globulin (IVIG) or plasma exchange (PLEX).
With the number of older adults in the U.S. predicted to double in the coming decades, how these individuals perceive the effects of aging may directly relate to how long and healthfully they live.
The race is on to develop new medications that effectively block pain receptors to help reduce the suffering of migraineurs.
The pandemic has left the healthcare system with staffing and revenue shortages, as well as supply chain management challenges, that are expected to extend into the foreseeable future.
Experts set the record straight about common misunderstandings regarding IVIG and SCIG products, their administration and possible reactions.
A new study demonstrates how severe acute respiratory syndrome coronavirus disease 2 (SARS-CoV-2) infection could be associated with an autoimmune response and development of autoantibodies.
Transition of clinic-based to home-based intravenous immune globulin (IVIG)/subcutaneous IG (SCIG) infusion can be successfully done to decrease potential exposure during a pandemic in a high-risk immunosuppressed population.
